Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression

Currently, there is no effective drugs for treating clinically COVID-19 except dexamethasone. We previously revealed that human identical sequences of SARS-CoV-2 promote the COVID-19 progression by upregulating hyaluronic acid (HA). As the inhibitor of HA synthesis, hymecromone is an approved prescr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuai, Ling, Yun, Zhao, Fang, Li, Wei, Song, Zhigang, Wang, Lu, Li, Qiuting, Liu, Mengxing, Tong, Ying, Chen, Lu, Ru, Daoping, Zhang, Tongsheng, Zhou, Kaicheng, Zhang, Baolong, Xu, Peng, Yang, Zhicong, Li, Wenxuan, Song, Yuanlin, Xu, Jianqing, Zhu, Tongyu, Shan, Fei, Yu, Wenqiang, Lu, Hongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931182/
https://www.ncbi.nlm.nih.gov/pubmed/35304437
http://dx.doi.org/10.1038/s41392-022-00952-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931182/
https://www.ncbi.nlm.nih.gov/pubmed/35304437
http://dx.doi.org/10.1038/s41392-022-00952-w

Ejemplares similares